K. Lauritsen

6.7k total citations · 1 hit paper
108 papers, 5.3k citations indexed

About

K. Lauritsen is a scholar working on Surgery, Gastroenterology and Epidemiology. According to data from OpenAlex, K. Lauritsen has authored 108 papers receiving a total of 5.3k indexed citations (citations by other indexed papers that have themselves been cited), including 75 papers in Surgery, 50 papers in Gastroenterology and 24 papers in Epidemiology. Recurrent topics in K. Lauritsen's work include Helicobacter pylori-related gastroenterology studies (59 papers), Gastroesophageal reflux and treatments (40 papers) and Eosinophilic Esophagitis (26 papers). K. Lauritsen is often cited by papers focused on Helicobacter pylori-related gastroenterology studies (59 papers), Gastroesophageal reflux and treatments (40 papers) and Eosinophilic Esophagitis (26 papers). K. Lauritsen collaborates with scholars based in Denmark, Sweden and Australia. K. Lauritsen's co-authors include J Rask-Madsen, Klaus Bukhave, Nicholas J. Talley, L. Laursen, Laurits S. Laursen, Troels Havelund, Ola Junghard, Tore Lind, A. Mark Fendrick and E. Bolling‐Sternevald and has published in prestigious journals such as New England Journal of Medicine, The Lancet and SHILAP Revista de lepidopterología.

In The Last Decade

K. Lauritsen

102 papers receiving 4.9k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

An evidence-based appraisal of reflux disease management — the Genval Workshop Report

1998 681 citations John Dent, Johan G. Brun et al. Gut profile →

Peers

K. Lauritsen

SURGE

GASTR

GENET

EPIDE

PRM

M J Langman United Kingdom

A. Walan Sweden

Neville D. Yeomans Australia

A Notarbartoló Italy

Walter Smalley United States

M. G. Korman Australia

Fred Kern United States

G. Bodemar Sweden

David J. Bjorkman United States

Masahiko Inamori Japan

M J Langman United Kingdom

K. Lauritsen

1.5k ×0.4

SURGE

831 ×0.3

GASTR

734 ×0.7

GENET

581 ×0.7

EPIDE

408 ×0.8

PRM

Citations per year, relative to K. Lauritsen K. Lauritsen (= 1×) peers M J Langman

Countries citing papers authored by K. Lauritsen

Since Specialization

Citations

This map shows the geographic impact of K. Lauritsen's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Lauritsen with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Lauritsen more than expected).

Fields of papers citing papers by K. Lauritsen

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Lauritsen. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Lauritsen. The network helps show where K. Lauritsen may publish in the future.

Co-authorship network of co-authors of K. Lauritsen

This figure shows the co-authorship network connecting the top 25 collaborators of K. Lauritsen. A scholar is included among the top collaborators of K. Lauritsen based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Lauritsen. K. Lauritsen is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Rutgeerts, Paul, Antoine Cortot, G. D’Haens, et al.. (2004). Effects of natalizumab on gut healing in a phase 3 study of active Crohn's disease therapy (ENACT-1). Gastroenterology. 9 indexed citations

Geboes, Karel, Antoine Cortot, G. D’Haens, et al.. (2004). Natalizumab decreases inflammatory cells within the colonic lamina propria of patients with active Crohn's disease: results from ENACT-1. Gastroenterology. 3 indexed citations

Lauritsen, K., et al.. (2004). Symptom recording in a randomised clinical trial: paper diaries vs. electronic or telephone data capture. Controlled Clinical Trials. 25(6). 585–597. 60 indexed citations

Armstrong, David, Nicholas J. Talley, K. Lauritsen, et al.. (2004). The role of acid suppression in patients with endoscopy-negative reflux disease: the effect of treatment with esomeprazole or omeprazole. Alimentary Pharmacology & Therapeutics. 20(4). 413–421. 70 indexed citations

Lauritsen, Jens, et al.. (1999). Helicobacter pylori and risk of ulcer bleeding among users of nonsteroidal anti-inflammatory drugs: A case-control study☆, ☆☆. Gastroenterology. 116(6). 1305–1309. 126 indexed citations

Talley, Nicholas J., J. Janssens, K. Lauritsen, I Rácz, & E. Bolling‐Sternevald. (1999). Eradication of Helicobacter pylori in functional dyspepsia: randomised double blind placebo controlled trial with 12 months' follow up. BMJ. 318(7187). 833–837. 227 indexed citations

Dent, John, Johan G. Brun, A. Mark Fendrick, et al.. (1998). An evidence-based appraisal of reflux disease management — the Genval Workshop Report. Gut. 44(suppl 2). S1–S16. 681 indexed citations breakdown →

Rask-Madsen, J, Klaus Bukhave, L. Laursen, & K. Lauritsen. (1992). 5-Lipoxygenase inhibitors for the treatment of inflammatory bowel disease.. PubMed. Spec No. C37–46. 53 indexed citations

Brynskov, Jørn, L Freund, Sten Nørby Rasmussen, et al.. (1991). Final Report on a Placebo-Controlled, Double-Blind, Randomized, Multicentre Trial of Cyclosporin Treatment in Active Chronic Crohn's Disease. Scandinavian Journal of Gastroenterology. 26(7). 689–695. 68 indexed citations

10.

Laursen, L., Morten Gersel Stokholm, Klaus Bukhave, J Rask-Madsen, & K. Lauritsen. (1990). Disposition of 5-aminosalicylic acid by olsalazine and three mesalazine preparations in patients with ulcerative colitis: comparison of intraluminal colonic concentrations, serum values, and urinary excretion.. Gut. 31(11). 1271–1276. 148 indexed citations

11.

Laursen, L., K. Lauritsen, J. Næsdal, J Rask-Madsen, & Klaus Bukhave. (1990). Selective 5-lipoxygenase inhibition in ulcerative colitis. The Lancet. 335(8691). 683–685. 101 indexed citations

12.

Lauritsen, K.. (1989). Omeprazole in the Treatment of Prepyloric Ulcer: Review of the Results of the Danish Omeprazole Study Group. Scandinavian Journal of Gastroenterology. 24(sup166). 54–57. 1 indexed citations

13.

Brynskov, Jørn, V. Binder, P Riis, et al.. (1989). Low‐dose cyclosporin for Crohn's disease: implications for clinical trials. Alimentary Pharmacology & Therapeutics. 3(2). 135–142. 16 indexed citations

14.

Lauritsen, K., L. Laursen, Klaus Bukhave, & J Rask-Madsen. (1989). Inflammatory intermediaries in inflammatory bowel disease. International Journal of Colorectal Disease. 4(2). 75–90. 39 indexed citations

15.

Lauritsen, K., L. Laursen, Klaus Bukhave, & J Rask-Madsen. (1988). Use of colonic eicosanoid concentrations as predictors of relapse in ulcerative colitis: double blind placebo controlled study on sulphasalazine maintenance treatment.. Gut. 29(10). 1316–1321. 36 indexed citations

16.

Lauritsen, K., L. Laursen, Klaus Bukhave, & J Rask-Madsen. (1987). In vivo effects of orally administered prednisolone on prostaglandin and leucotriene production in ulcerative colitis.. Gut. 28(9). 1095–1099. 75 indexed citations

17.

Havelund, Troels, et al.. (1987). Effects of Cisapride on Gastroparesis in Patients with Insulin‐dependent Diabetes Mellitus. Acta Medica Scandinavica. 222(4). 339–343. 42 indexed citations

18.

Lauritsen, K., L. Laursen, Troels Havelund, et al.. (1986). Enprostil and ranitidine in duodenal ulcer healing: double blind comparative trial.. BMJ. 292(6524). 864–866. 39 indexed citations

19.

Lauritsen, K., L. Laursen, Troels Havelund, Peter Bytzer, & J Rask-Madsen. (1985). Arbaprostil in bleeding peptic ulcer. BMJ. 291(6509). 1648.2–1648. 1 indexed citations

20.

Lauritsen, K., L. Laursen, Troels Havelund, Peter Bytzer, & J Rask-Madsen. (1985). Controlled trial of arbaprostil in bleeding peptic ulcer.. BMJ. 291(6502). 1093–1093. 13 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact